Nxera Pharma SOLTF Stock
Nxera Pharma Price Chart
Nxera Pharma SOLTF Financial and Trading Overview
| Nxera Pharma stock price | 5.5 USD |
| Previous Close | 21.33 USD |
| Open | 21.5 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 21.33 - 21.33 USD |
| 52 Week Range | 8.44 - 22.78 USD |
| Volume | 5.2K USD |
| Avg. Volume | 574 USD |
| Market Cap | 1.75B USD |
| Beta (5Y Monthly) | 0.946743 |
| PE Ratio (TTM) | 711 |
| EPS (TTM) | -0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 27, 2015 |
| 1y Target Est | N/A |
SOLTF Valuation Measures
| Enterprise Value | -34725584896 USD |
| Trailing P/E | 711 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.11352027 |
| Price/Book (mrq) | 0.030017141 |
| Enterprise Value/Revenue | -2.256 |
| Enterprise Value/EBITDA | -7.867 |
Trading Information
Nxera Pharma Stock Price History
| Beta (5Y Monthly) | 0.946743 |
| 52-Week Change | 152.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 22.78 USD |
| 52 Week Low | 8.44 USD |
| 50-Day Moving Average | 20.49 USD |
| 200-Day Moving Average | 14.68 USD |
SOLTF Share Statistics
| Avg. Volume (3 month) | 574 USD |
| Avg. Daily Volume (10-Days) | 550 USD |
| Shares Outstanding | 81.92M |
| Float | 62.44M |
| Short Ratio | N/A |
| % Held by Insiders | 10.32% |
| % Held by Institutions | 30.73% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 100:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.82% |
| Operating Margin (ttm) | 19.83% |
| Gross Margin | 95.25% |
| EBITDA Margin | 28.67% |
Management Effectiveness
| Return on Assets (ttm) | 1.96% |
| Return on Equity (ttm) | 1.83% |
Income Statement
| Revenue (ttm) | 15.39B USD |
| Revenue Per Share (ttm) | 187.98 USD |
| Quarterly Revenue Growth (yoy) | -15.69% |
| Gross Profit (ttm) | 14.64B USD |
| EBITDA | 4.41B USD |
| Net Income Avi to Common (ttm) | 1.05B USD |
| Diluted EPS (ttm) | 0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 66.35B USD |
| Total Cash Per Share (mrq) | 809.93 USD |
| Total Debt (mrq) | 29.88B USD |
| Total Debt/Equity (mrq) | 51.33 USD |
| Current Ratio (mrq) | 20.416 |
| Book Value Per Share (mrq) | 710.594 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 10.39B USD |
| Levered Free Cash Flow (ttm) | -1253250048 USD |
Profile of Nxera Pharma
| Country | United States |
| State | N/A |
| City | Tokyo |
| Address | PMO Hanzomon |
| ZIP | 102-0083 |
| Phone | 81 3 5210 3290 |
| Website | https://soseiheptares.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 207 |
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.
Q&A For Nxera Pharma Stock
What is a current SOLTF stock price?
Nxera Pharma SOLTF stock price today per share is 5.5 USD.
How to purchase Nxera Pharma stock?
You can buy SOLTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nxera Pharma?
The stock symbol or ticker of Nxera Pharma is SOLTF.
Which industry does the Nxera Pharma company belong to?
The Nxera Pharma industry is Biotechnology.
How many shares does Nxera Pharma have in circulation?
The max supply of Nxera Pharma shares is 93.6M.
What is Nxera Pharma Price to Earnings Ratio (PE Ratio)?
Nxera Pharma PE Ratio is now.
What was Nxera Pharma earnings per share over the trailing 12 months (TTM)?
Nxera Pharma EPS is -0.18 USD over the trailing 12 months.
Which sector does the Nxera Pharma company belong to?
The Nxera Pharma sector is Healthcare.